DBV Technologies SA
0.5960
26-November-24 10:25:56
15 minutes delayed
Stocks
+0.0660
+12.45%
Today's range
0.5260 - 0.7200
ISIN
FR0010417345
Source
Cboe
-
16 Jun 2023 15:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming EAACI Congress 2023
08 Jun 2023 15:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming Investor Conference
06 Jun 2023 16:00:00 By Nasdaq GlobeNewswire
-
10 May 2023 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming Investor Conference
09 May 2023 15:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies Reports First Quarter 2023 Financial Results
04 May 2023 15:30:00 By Nasdaq GlobeNewswire
-
19 Apr 2023 16:09:21 By Nasdaq GlobeNewswire
-
DBV Technologies Announces Results of its 2023 Ordinary and Extraordinary General Meeting
12 Apr 2023 15:30:00 By Nasdaq GlobeNewswire
-
Ordinary and Extraordinary General Meeting of April 12, 2023
24 Mar 2023 15:30:00 By Nasdaq GlobeNewswire
-
13 Mar 2023 00:30:00 By Nasdaq GlobeNewswire
-
07 Mar 2023 15:30:00 By Nasdaq GlobeNewswire
-
02 Mar 2023 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies Reports Full Year 2022 Financial Results and Business Update
02 Mar 2023 15:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming AAAAI 2023 Congress
21 Feb 2023 15:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming Investor Conference
10 Feb 2023 15:30:00 By Nasdaq GlobeNewswire
-
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
23 Jan 2023 15:30:00 By Nasdaq GlobeNewswire
-
04 Jan 2023 15:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
23 Dec 2022 00:30:00 By Nasdaq GlobeNewswire
-
08 Dec 2022 15:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming Investor Conference
22 Nov 2022 15:30:00 By Nasdaq GlobeNewswire